Aegerion Pharma (AEGR) Holders Vote to Adopt Agreement and Plan of Merger

November 8, 2016 7:58 AM EST

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Aegerion Pharma (NASDAQ: AEGR) disclosed in an SEC filing:

On November 7, 2016, Aegerion Pharmaceuticals, Inc. (the “Company”) held a special meeting of stockholders to consider and vote on the proposals set forth in the definitive proxy statement filed by the Company on October 6, 2016. The following is a summary of the matters voted on by the Company’s stockholders at the special meeting:
(1)
Agreement and Plan of Merger: The stockholders voted to adopt the Agreement and Plan of Merger, dated as of June 14, 2016 (as amended, the “merger agreement”), by and among the Company, QLT Inc. (“QLT”) and Isotope Acquisition Corp., an indirect wholly-owned subsidiary of QLT (“MergerCo”). The merger agreement provides for the merger of MergerCo with and into the Company (the “merger”), with the Company surviving as an indirect wholly-owned subsidiary of QLT.
The number of shares cast in favor and against the proposal and the number of abstentions and broker non-votes were as follows:
Votes For
Votes Against
Abstain
Broker Non-Votes
22,694,521
12,995
30,828
0
(2)
Advisory Vote on Executive Compensation: The stockholders voted to approve, on an advisory, non-binding basis, specific compensatory arrangements between the Company and its named executive officers relating to the merger.
The number of shares cast in favor and against the proposal and the number of abstentions and broker non-votes were as follows:
Votes For
Votes Against
Abstain
Broker Non-Votes
22,205,206
492,513
40,625
0


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Corporate News, Mergers and Acquisitions

Related Entities

Definitive Agreement

Add Your Comment